Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.41 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.71NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AS.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.142NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.166NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.11 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.34.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.315NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.204NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21309.6South Korea
B.1.177.50NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.170NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.232NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.84NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.76NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.301NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.269NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.165NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
V.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.149NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.413NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.107NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDFNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.575.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GK.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.620NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDMNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.46.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.16 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.34.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.55NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.39NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.64NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used